RhumbLine Advisers’s XTL Biopharmaceuticals XTLB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$20K	Buy	17,261 +6,307	+58%	+$7.32K	﹤0.01%	3795
2025 Q1	$13.6K	Hold	10,954	–	–	﹤0.01%	3788
2024 Q4	$22.6K	Buy	10,954 +4,435	+68%	+$9.14K	﹤0.01%	3790
2024 Q3	$15.8K	Buy	6,519 +935	+17%	+$2.26K	﹤0.01%	3843
2024 Q2	$13.2K	Buy	+5,584	New	+$13.2K	﹤0.01%	3940